A 6-month Study to Evaluate Sulforaphane Effects in PD Patients

NCT05084365 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Sulforaphane
DRUG: Placebo

Sponsor

Central South University